Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase

Journal of Structural Biology

Volumn 116, Issue 2, 1996, Pages 320-325

  Zhao, Qiang ^a   Smith, Graeme ^b   Modi, Sandeep ^c   Paine, Mark ^b   Wolf, Roland C ^b   David, Tew ^d   Lian, Lu Yun ^c   Primrose, William U ^c   Roberts, Gordon C K ^c   Driessen, Huub P C ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 REDUCTASE;

ARTICLE; CRYSTALLIZATION; ENZYME STRUCTURE; HUMAN; PRIORITY JOURNAL; X RAY DIFFRACTION;

ESCHERICHIA COLI;

EID: 0030004601     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1996.0048     Document Type: Article

References (38)

1. Arnold, F. H. (1991) Metal-affinity separations - A new dimension in protein processing, Biotechnology 9, 151-156.
2. Bartoszek, A., and Wolf, C. R. (1992) Enhancement of doxorubicin toxicity following activation by NADPH cytochrome P450 reductase, Biochem. Pharmacol. 43, 1449-1457.
3. Bastiaens, P. I., Bonants, P. J., Muller, F., and Visser, A. J. (1989) Time-resolved fluorescence spectroscopy of NADPH cytochrome-P450-reductase - Demonstration of energy transfer between the two prosthetic groups, Biochemistry 28, 8416-8425.
4. Bligh, H. F. J., Bartoszek, A., Robson, C. N., Hickson, I. D., Kaspaer, C. B., Begg, J. D., and Wolf, C. R. (1990) Activation of mitomycin c by NADPH:Cytochrome P450 reductase, Cancer Res. 50, 7789-7792.
5. Blumberg, W. E., Nisimoto, Y., and Mason, H. S. (1982) in Nozake M., Yamamoto S., Ishimura Y., Coon M. J., Ernster L., and Estabrook R. (Eds.), Oxygenases and Oxygen Metabolism, pp. 333-343, Academic Press, New York.
6. Bonants, P. J., Muller, F., Vervoort, J., and Edmondson, D. E. (1990) A P-31-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin ferredoxin-NADP+ reductase complex, Eur. J. Biochem. 190, 531-537.
7. (1994) The CCP4 Suite: Programs for protein crystallography, Acta Crystallogr. D50, 760-763.
8. Djordjevic, S., Roberts, D. L., Wang, M., Shea, T., Camitta, M. G. W., Masters, B. S. S., and Kim, J. J. P. (1995) Crystallization and preliminary x-ray studies of NADPH-cytochrome P450 reductase, Proc. Natl. Acad. Sci. USA 92, 3214-3218.
9. 5 reduction by NADPH-cytochrome P450 reductase, J. Biol. Chem. 254, 8976-8981.
10. Ilan, Z., Ilan, R., and Cinti, D. L. (1981) Evidence for a new physiological role of hepatic NADPH: Ferricytochrome (P-450) oxidoreductase, J. Biol. Chem. 256, 10066-10072.
11. Iyanagi, T., and Mason, H. S. (1973) Some properties of hepatic reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase, Biochemistry 12, 2297-2308.
12. Jancarik, J., and Kim, S. H. (1991) Sparse matrix sampling: A screening method for crystallization of proteins, J. Appl. Crystallogr. 24, 409-411.
13. + reductase: Prototype for a structurally novel flavoenzyme family, Science 251, 60-65.
14. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. (1984) Role of NADPH: Cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin c, Cancer Res. 44, 5638-5643.
15. Lively, C., Domanski, D., Masters, B. S. S., and McFarland, J. T. (1984) in Ninth International Conference on Raman Spectroscopy, pp. 146-147, Chem. Soc. Japan, Tokyo.
16. Lu, A. Y. H., Junk, K. W., and Coon, M. J. (1969) Resolution of the cytochrome P-450-containing ω-hydroxylation system of liver microsomes into three components, J. Biol. Chem. 244, 3714-3721.
17. Lu, A. Y. H., and Levin, W. (1974) The resolution and reconstitution of the liver microsomal hydroxylation system, Biochim. Biophys. Acta 344, 205-240.
18. Matthews, B. W. (1968) Solvent content of protein crystals, J. Mol. Biol. 33, 491-497.
19. McPherson, A., Koszelak, S., Axelrod, H., Day, J., Williams, R., Robinson, L., McGrath, M., and Cascio, D. (1986) An experiment regarding crystallization of soluble proteins in the presence of β-octyl-glucoside, J. Biol. Chem. 261, 1969-1975.
20. Narayanasami, R., Otvos, J. D., Kasper, C. B., Shen, A., Rajagopalan, J., McCabe, T. J., Okita, J. R., Hanahan, D. J., and Masters, B. S. S. (1992) P-31 NMR spectroscopic studies on purified, native and cloned, expressed forms of NADPH-cytochrome-P450 reductase, Biochemistry 31, 4210-4218.
21. Nebert, D. W. (1979) Multiple forms of inducible drug-metabolizing enzymes: A reasonable mechanism by which any organism can copy with adversity, Mol. Cell. Biochem. 27, 27-46.
22. Ostrowski, J., Barber, M. J., Rueger, D. C., Miller, B. E., Siegel, L. M., and Kredich, N. M. (1989) Characterization of the flavoprotein moieties of NADPH-sulfite reductase from Salmonella typhimurium and Escherichia coli, J. Biol. Chem. 264, 15796-15808.
23. Otvos, J. D., Krum, D. P., and Masters, B. S. S. (1986) Localization of the free-radical on the flavin mononucleotide of the airstable semiquinone state of NADPH-cytochrome P-450 reductase using P-31 NMR-spectroscopy, Biochemistry 25, 7220-7228.
24. Otwinowski, Z. (1993) Oscillation data reduction program, in Sawyer L., Isaacs N., and Bailey S., (Eds.), Data Collection and Processing, CCP4 Daresbury Study Weekend, pp. 56-62, Daresbury Laboratory, Warrington, UK.
25. Philips, A. H., and Langdon, R. G. (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization, and kinetic studies, J. Biol. Chem. 237, 2652-2660.
26. Porter, T. D. (1991) An unusual yet strongly conserved flavoprotein reductase in bacteria and mammals, Trends Biochem. Sci. 16, 154-158.
27. Porter, T. D., and Kasper, C. B. (1986) NADPH-cytochrome P450 oxidoreductase: Flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins, Biochemistry 25, 1682-1687.
28. Prince, R. C., and Gunson, D. E. (1993) Rising interest in nitric oxide synthase, Trends Biochem. Sci. 18, 35-36.
29. Schacter, B. A., Nelson, E. B., Marver, H. S., and Masters, B. S. S. (1972) Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system, J. Biol. Chem. 247, 3601-3607.
30. -245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes, Biochem. J. 284, 781-788.
31. Sevanian, A., Nordenbrand, K., Kim, E., Ernster, L., and Hochstein, P. (1990) Microsomal lipid peroxidation: The role of NADPH-cytochrome P450 reductase and cytochrome P450, Free Radical Biol. Med. 8, 145-152.
32. Smith, G. C. M., Tew, D. G., and Wolf, C. R. (1994) Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains, Proc. Natl. Acad. Sci. USA 91, 8710-8714.
33. Sugiyama, T., Nisimoto, Y., Mason, H. S., and Loehr, T. M. (1985) Flavins of NADPH-cytochrome P-450 reductase: Evidence for structural alteration of flavins in their one-electron-reduced semiquinone states from resonance Raman spectroscopy, Biochemistry 24, 3012-3019.
34. Vermilion, J. L., Ballou, D. P., Massey, V., and Coon, M. J. (1981) Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase, J. Biol. Chem. 256, 266-277.
35. Walton, M. I., Wolf, C. R., and Workman, P. (1992) The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-n-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver, Biochem. Pharmacol. 44, 251-259.
36. White, R. E., and Coon, M. J. (1980) Oxygen activation by cytochrome P450, Annu. Rev. Biochem. 49, 315-356.
37. Williams, C. H., and Kamin, H. (1962) Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver, J. Biol. Chem. 237, 587-595.
38. Yasukochi, Y., Peterson, J. A., and Masters, B. S. S. (1979) NADPH-cytochrome c (P450) reductase: Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates, J. Biol. Chem. 254, 7097-7104.